$UHT
UNIVERSAL HEALTH REALTY INCOME TRUST

2023 Q2 Form 10-Q Financial Statement

#000095017023019195 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $23.81M $23.23M $22.18M
YoY Change 7.37% 4.74% 7.13%
Cost Of Revenue $8.250M $7.521M $6.867M
YoY Change 18.09% 9.52% 22.63%
Gross Profit $15.56M $15.71M $15.31M
YoY Change 2.44% 2.59% 1.38%
Gross Profit Margin 65.34% 67.62% 69.03%
Selling, General & Admin $1.323M $1.302M $1.224M
YoY Change 4.5% 6.37% 15.47%
% of Gross Profit 8.5% 8.29% 8.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.849M $6.618M $6.709M
YoY Change 2.55% -1.36% -1.15%
% of Gross Profit 44.03% 42.14% 43.83%
Operating Expenses $8.172M $7.920M $7.920M
YoY Change 3.03% 0.0% 0.76%
Operating Profit $7.384M $7.785M $7.388M
YoY Change 1.99% 5.37% 1.93%
Interest Expense -$3.908M -$3.326M -$1.983M
YoY Change 92.04% 67.73% 20.18%
% of Operating Profit -52.93% -42.72% -26.84%
Other Income/Expense, Net
YoY Change
Pretax Income $3.476M $4.459M $5.405M
YoY Change -33.38% -17.5% -3.31%
Income Tax
% Of Pretax Income
Net Earnings $3.476M $4.459M $5.405M
YoY Change -33.38% -17.5% -3.24%
Net Earnings / Revenue 14.6% 19.2% 24.37%
Basic Earnings Per Share $0.25 $0.32 $0.39
Diluted Earnings Per Share $0.25 $0.32 $392.1K
COMMON SHARES
Basic Shares Outstanding 13.80M 13.80M 13.76M
Diluted Shares Outstanding 13.81M 13.80M 13.79M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.459M $8.120M $8.879M
YoY Change 12.62% -8.55% 43.21%
Cash & Equivalents $9.459M $8.120M $8.879M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $23.78M $22.49M $21.04M
YoY Change 14.0% 6.88% 22.32%
LONG-TERM ASSETS
Property, Plant & Equipment $458.2M $459.4M $459.4M
YoY Change -0.61% -0.01% 2.11%
Goodwill
YoY Change
Intangibles $8.343M $8.877M $11.18M
YoY Change -20.9% -20.56% 1.47%
Long-Term Investments $9.296M $9.599M $9.960M
YoY Change -4.29% -3.62% 9.45%
Other Assets $20.20M $20.44M $17.12M
YoY Change 12.65% 19.39% 99.06%
Total Long-Term Assets $579.5M $581.8M $581.4M
YoY Change -0.59% 0.07% 21.48%
TOTAL ASSETS
Total Short-Term Assets $23.78M $22.49M $21.04M
Total Long-Term Assets $579.5M $581.8M $581.4M
Total Assets $603.3M $604.3M $602.4M
YoY Change -0.08% 0.31% 21.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $24.22M $22.53M $23.61M
YoY Change 0.58% -4.55% 14.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.22M $22.53M $23.61M
YoY Change 0.58% -4.55% 14.6%
LONG-TERM LIABILITIES
Long-Term Debt $351.1M $348.5M $331.4M
YoY Change 4.81% 5.15% 8.28%
Other Long-Term Liabilities $11.31M $11.09M $10.42M
YoY Change 12.51% 6.42% 0.2%
Total Long-Term Liabilities $362.5M $359.6M $341.9M
YoY Change 5.03% 5.19% 8.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.22M $22.53M $23.61M
Total Long-Term Liabilities $362.5M $359.6M $341.9M
Total Liabilities $386.7M $382.1M $365.5M
YoY Change 4.74% 4.56% 8.41%
SHAREHOLDERS EQUITY
Retained Earnings $818.6M $815.1M $795.0M
YoY Change 2.3% 2.54% 15.83%
Common Stock $270.1M $269.8M $268.9M
YoY Change 0.33% 0.34% 0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $216.6M $222.2M $237.0M
YoY Change
Total Liabilities & Shareholders Equity $603.3M $604.3M $602.4M
YoY Change -0.08% 0.31% 21.51%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $3.476M $4.459M $5.405M
YoY Change -33.38% -17.5% -3.24%
Depreciation, Depletion And Amortization $6.849M $6.618M $6.709M
YoY Change 2.55% -1.36% -1.15%
Cash From Operating Activities $12.25M $10.07M $11.70M
YoY Change -7.42% -13.98% 4.04%
INVESTING ACTIVITIES
Capital Expenditures $3.786M $5.003M $13.61M
YoY Change -149.1% -63.23% -295.19%
Acquisitions
YoY Change
Other Investing Activities $305.0K -$405.0K $160.0K
YoY Change 32.03% -353.13% -103.05%
Cash From Investing Activities -$3.481M -$5.408M -$18.32M
YoY Change -53.46% -70.48% 49.93%
FINANCING ACTIVITIES
Cash Dividend Paid $10.00M $9.900M $9.700M
YoY Change 2.04% 2.06% 1.04%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.434M -4.154M -7.011M
YoY Change 19.21% -40.75% -601.86%
NET CHANGE
Cash From Operating Activities 12.25M 10.07M 11.70M
Cash From Investing Activities -3.481M -5.408M -18.32M
Cash From Financing Activities -7.434M -4.154M -7.011M
Net Change In Cash 1.339M 506.0K -13.63M
YoY Change -378.96% -103.71% -3275.99%
FREE CASH FLOW
Cash From Operating Activities $12.25M $10.07M $11.70M
Capital Expenditures $3.786M $5.003M $13.61M
Free Cash Flow $8.468M $5.065M -$1.901M
YoY Change -59.57% -366.44% -110.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
uht Number Of Businesses Disposed
NumberOfBusinessesDisposed
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000798783
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-9321
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL HEALTH REALTY INCOME TRUST
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-6858580
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
UNIVERSAL CORPORATE CENTER
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
367 SOUTH GULPH ROAD
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
KING OF PRUSSIA
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19406-0958
CY2023Q1 dei City Area Code
CityAreaCode
610
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
265-0688
CY2023Q1 dei Security12b Title
Security12bTitle
Shares of beneficial interest, $0.01 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
UHT
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13804145
CY2023Q1 us-gaap Revenues
Revenues
23226000
CY2022Q1 us-gaap Revenues
Revenues
22175000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6618000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6709000
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7521000
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6867000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
15441000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
14800000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7785000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7375000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
371000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
252000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3697000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2222000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4459000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5405000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13778000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13764000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13803000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13785000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4459000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5405000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1747000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
5684000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1747000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5684000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2712000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11089000
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
645509000
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
641338000
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
254590000
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
248772000
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
390919000
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
392566000
CY2023Q1 us-gaap Land
Land
56631000
CY2022Q4 us-gaap Land
Land
56631000
CY2023Q1 us-gaap Real Estate Investments
RealEstateInvestments
447550000
CY2022Q4 us-gaap Real Estate Investments
RealEstateInvestments
449197000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
83525000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
83603000
CY2023Q1 us-gaap Investments
Investments
531075000
CY2022Q4 us-gaap Investments
Investments
532800000
CY2023Q1 us-gaap Investments In And Advances To Affiliates At Fair Value
InvestmentsInAndAdvancesToAffiliatesAtFairValue
9599000
CY2022Q4 us-gaap Investments In And Advances To Affiliates At Fair Value
InvestmentsInAndAdvancesToAffiliatesAtFairValue
9282000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8120000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7614000
CY2023Q1 uht Lease And Other Receivables
LeaseAndOtherReceivables
5755000
CY2022Q4 uht Lease And Other Receivables
LeaseAndOtherReceivables
5388000
CY2023Q1 uht Lease Receivable Other
LeaseReceivableOther
8611000
CY2022Q4 uht Lease Receivable Other
LeaseReceivableOther
8445000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14100000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15400000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8877000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9447000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11836000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11457000
CY2023Q1 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
20439000
CY2022Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
23107000
CY2023Q1 us-gaap Assets
Assets
604312000
CY2022Q4 us-gaap Assets
Assets
607540000
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
308400000
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
298100000
CY2023Q1 us-gaap Secured Debt
SecuredDebt
40119000
CY2022Q4 us-gaap Secured Debt
SecuredDebt
44725000
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
337000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
373000
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
10360000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
12873000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
11836000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
11457000
CY2023Q1 uht Tenant Reserves Deposits And Deferred And Prepaid Rents
TenantReservesDepositsAndDeferredAndPrepaidRents
11090000
CY2022Q4 uht Tenant Reserves Deposits And Deferred And Prepaid Rents
TenantReservesDepositsAndDeferredAndPrepaidRents
10911000
CY2023Q1 us-gaap Liabilities
Liabilities
382142000
CY2022Q4 us-gaap Liabilities
Liabilities
378439000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13804142
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13804142
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13803335
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13803335
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
138000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
138000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
269698000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
269472000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
815120000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
810661000
CY2023Q1 us-gaap Cumulative Dividends
CumulativeDividends
873050000
CY2022Q4 us-gaap Cumulative Dividends
CumulativeDividends
863181000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10264000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12011000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
222170000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
229101000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
604312000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
607540000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
229101000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
188000
CY2023Q1 uht Dividends Per Share
DividendsPerShare
0.715
CY2023Q1 us-gaap Dividends
Dividends
9869000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4459000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1747000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2712000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
222170000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
235327000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
54000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
223000
CY2022Q1 uht Dividends Per Share
DividendsPerShare
0.705
CY2022Q1 us-gaap Dividends
Dividends
9719000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5405000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
5684000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
11089000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
236974000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
4459000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
5405000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6618000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6709000
CY2023Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-39000
CY2022Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-39000
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-12000
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-12000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
171000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
176000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
188000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
223000
CY2023Q1 us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
533000
CY2022Q1 us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
410000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1610000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-613000
CY2023Q1 uht Increase Decrease In Tenant Reserves Deposits Deferred And Prepaid Rents
IncreaseDecreaseInTenantReservesDepositsDeferredAndPrepaidRents
179000
CY2022Q1 uht Increase Decrease In Tenant Reserves Deposits Deferred And Prepaid Rents
IncreaseDecreaseInTenantReservesDepositsDeferredAndPrepaidRents
93000
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
36000
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
3000
CY2023Q1 uht Increase Decrease In Leasing Costs
IncreaseDecreaseInLeasingCosts
200000
CY2022Q1 uht Increase Decrease In Leasing Costs
IncreaseDecreaseInLeasingCosts
482000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-883000
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-657000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10068000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11704000
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3869000
CY2023Q1 uht Cash Distributions In Excess Of Income From Limited Liability Companies
CashDistributionsInExcessOfIncomeFromLimitedLiabilityCompanies
64000
CY2022Q1 uht Cash Distributions In Excess Of Income From Limited Liability Companies
CashDistributionsInExcessOfIncomeFromLimitedLiabilityCompanies
160000
CY2023Q1 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
3500000
CY2023Q1 us-gaap Real Estate Period Increase Decrease
RealEstatePeriodIncreaseDecrease
-5003000
CY2022Q1 us-gaap Real Estate Period Increase Decrease
RealEstatePeriodIncreaseDecrease
-3527000
CY2023Q1 uht Payments For Deposit On Real Estate Assets
PaymentsForDepositOnRealEstateAssets
100000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13605000
CY2022Q1 uht Payments To Asset Exchange Transaction
PaymentsToAssetExchangeTransaction
-1346000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5408000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18318000
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10300000
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3200000
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.70
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
4612000
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
536000
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
30000
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
26000
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
9851000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
9704000
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
39000
CY2022Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
55000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4154000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7011000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
506000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13625000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7614000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22504000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8120000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8879000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
3723000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
2080000
CY2023Q1 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
832000
CY2022Q1 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
1932000
CY2023Q1 uht Number Of Bed Facility
NumberOfBedFacility
100
CY2023Q1 uht Annual Advisory Fees As Percentage Of Average Invested Real Estate Assets
AnnualAdvisoryFeesAsPercentageOfAverageInvestedRealEstateAssets
0.0070
CY2022Q1 uht Annual Advisory Fees As Percentage Of Average Invested Real Estate Assets
AnnualAdvisoryFeesAsPercentageOfAverageInvestedRealEstateAssets
0.0070
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
9900000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.715
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
9700000
CY2023Q1 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
0
CY2023Q1 uht Number Of Businesses Disposed
NumberOfBusinessesDisposed
0
CY2023Q1 uht Number Of Properties
NumberOfProperties
2
CY2023Q1 uht Operating Expenses Excluding Depreciation And Amortization Expense
OperatingExpensesExcludingDepreciationAndAmortizationExpense
187000
CY2022Q1 uht Operating Expenses Excluding Depreciation And Amortization Expense
OperatingExpensesExcludingDepreciationAndAmortizationExpense
175000
CY2023Q1 uht Number Of Ground Leases For Land
NumberOfGroundLeasesForLand
15
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11800000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
11800000
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
308400000
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3100000
CY2023Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
63500000
CY2023Q1 us-gaap Compensating Balance Amount
CompensatingBalanceAmount
0
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
298100000
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3100000
CY2022Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
73800000
CY2023Q1 uht Debt Instrument Covenant Tangible Net Worth
DebtInstrumentCovenantTangibleNetWorth
125000000
CY2023Q1 uht Tangible Net Worth
TangibleNetWorth
213293000
CY2022Q4 uht Tangible Net Worth
TangibleNetWorth
219654000
CY2023Q1 uht Leverage Ratio
LeverageRatio
0.434
CY2022Q4 uht Leverage Ratio
LeverageRatio
0.429
CY2023Q1 uht Secured Leverage Ratio
SecuredLeverageRatio
0.050
CY2022Q4 uht Secured Leverage Ratio
SecuredLeverageRatio
0.056
CY2023Q1 uht Unencumbered Leverage Ratio
UnencumberedLeverageRatio
0.427
CY2022Q4 uht Unencumbered Leverage Ratio
UnencumberedLeverageRatio
0.418
CY2023Q1 uht Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
0.040
CY2022Q4 uht Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
0.043
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1

Files In Submission

Name View Source Status
uht-20230331_cal.xml Edgar Link unprocessable
0000950170-23-019195-index-headers.html Edgar Link pending
0000950170-23-019195-index.html Edgar Link pending
0000950170-23-019195.txt Edgar Link pending
0000950170-23-019195-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uht-20230331.htm Edgar Link pending
uht-20230331.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
uht-20230331_def.xml Edgar Link unprocessable
uht-20230331_lab.xml Edgar Link unprocessable
uht-20230331_htm.xml Edgar Link completed
uht-ex31_1.htm Edgar Link pending
uht-ex31_2.htm Edgar Link pending
uht-ex32_1.htm Edgar Link pending
uht-ex32_2.htm Edgar Link pending
uht-20230331_pre.xml Edgar Link unprocessable